药厂巨头迫使特朗普管理者 阻止医疗药品价格谈判 维持高昂的成本 Pharma giants pressure Trump admin to block Medicare drug price negotiations, maintaining high costs.

大制药公司正在向特朗普政府施压,要求放松规则,使医疗保险公司能够直接与它们谈判药品价格。 Big pharmaceutical companies are pressuring the Trump administration to loosen rules that allow Medicare to negotiate drug prices directly with them. 此举旨在维持目前的定价战略,批评者认为这增加了消费者的成本。 This move aims to maintain current pricing strategies, which critics argue inflate costs for consumers.